A detailed history of Ifp Advisors, Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 9,124 shares of ZTS stock, worth $1.61 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,124
Previous 7,858 16.11%
Holding current value
$1.61 Million
Previous $1.33 Million 18.96%
% of portfolio
0.07%
Previous 0.06%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$145.54 - $178.83 $184,253 - $226,398
1,266 Added 16.11%
9,124 $1.58 Million
Q1 2024

Jul 30, 2024

BUY
$165.67 - $199.94 $29,986 - $36,189
181 Added 2.36%
7,858 $1.33 Million
Q4 2023

Jan 09, 2024

BUY
$151.44 - $200.09 $27,107 - $35,816
179 Added 2.39%
7,677 $1.52 Million
Q3 2023

Oct 12, 2023

SELL
$167.14 - $192.77 $2.11 Million - $2.43 Million
-12,619 Reduced 62.73%
7,498 $1.3 Million
Q2 2023

Aug 04, 2023

SELL
$160.94 - $186.23 $2.79 Million - $3.23 Million
-17,342 Reduced 46.3%
20,117 $3.46 Million
Q1 2023

Apr 18, 2023

SELL
$145.48 - $175.02 $551,223 - $663,150
-3,789 Reduced 9.19%
37,459 $6.23 Million
Q4 2022

Feb 07, 2023

BUY
$131.14 - $157.47 $771,758 - $926,710
5,885 Added 16.64%
41,248 $3.57 Million
Q3 2022

Nov 08, 2022

BUY
$148.29 - $182.55 $342,549 - $421,690
2,310 Added 6.99%
35,363 $4.2 Million
Q2 2022

Sep 06, 2022

BUY
$155.97 - $200.09 $5.15 Million - $6.61 Million
33,041 Added 275341.66%
33,053 $3.99 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $5.15 Million - $6.61 Million
-33,041 Reduced 99.96%
12 $1,000
Q1 2022

Sep 06, 2022

BUY
$181.39 - $234.03 $415,927 - $536,630
2,293 Added 7.45%
33,053 $6.23 Million
Q1 2022

Aug 08, 2022

BUY
$181.39 - $234.03 $447,307 - $577,117
2,466 Added 8.72%
30,760 $5.8 Million
Q4 2021

Jan 12, 2022

SELL
$193.69 - $247.03 $37,575 - $47,923
-194 Reduced 0.68%
28,294 $6.89 Million
Q3 2021

Oct 06, 2021

BUY
$189.29 - $209.69 $127,392 - $141,121
673 Added 2.42%
28,488 $5.54 Million
Q2 2021

Jul 13, 2021

BUY
$155.9 - $187.99 $123,316 - $148,700
791 Added 2.93%
27,815 $5.18 Million
Q1 2021

Apr 30, 2021

BUY
$144.0 - $169.39 $672,480 - $791,051
4,670 Added 20.89%
27,024 $4.26 Million
Q4 2020

Jan 25, 2021

BUY
$157.07 - $174.35 $300,789 - $333,880
1,915 Added 9.37%
22,354 $3.69 Million
Q3 2020

Oct 29, 2020

BUY
$137.1 - $165.37 $76,913 - $92,772
561 Added 2.82%
20,439 $3.38 Million
Q2 2020

Aug 05, 2020

BUY
$111.92 - $142.53 $317,181 - $403,930
2,834 Added 16.63%
19,878 $2.62 Million
Q1 2020

May 12, 2020

BUY
$92.66 - $144.94 $112,118 - $175,377
1,210 Added 7.64%
17,044 $2 Million
Q4 2019

Jan 17, 2020

BUY
$116.25 - $133.25 $955,807 - $1.1 Million
8,222 Added 108.01%
15,834 $2.1 Million
Q3 2019

Nov 07, 2019

BUY
$112.57 - $128.43 $830,541 - $947,556
7,378 Added 3152.99%
7,612 $941,000
Q1 2019

May 15, 2019

SELL
$81.56 - $100.67 $1.56 Million - $1.92 Million
-19,091 Reduced 98.79%
234 $22,000
Q4 2018

Jan 23, 2019

BUY
$79.28 - $95.27 $32,901 - $39,537
415 Added 2.19%
19,325 $1.65 Million
Q3 2018

Oct 25, 2018

SELL
$83.5 - $93.23 $28,724 - $32,071
-344 Reduced 1.79%
18,910 $0
Q2 2018

Aug 07, 2018

BUY
$79.9 - $89.2 $232,349 - $259,393
2,908 Added 17.79%
19,254 $0
Q1 2018

Jun 03, 2019

BUY
$71.51 - $84.69 $21,309 - $25,237
298 Added 1.86%
16,346 $1.18 Million
Q1 2018

May 09, 2018

SELL
$71.51 - $84.69 $21,309 - $25,237
-298 Reduced 1.82%
16,048 $0
Q4 2017

Jan 24, 2018

SELL
$63.24 - $72.8 $59,129 - $68,068
-935 Reduced 5.41%
16,346 $0
Q3 2017

Oct 30, 2017

SELL
$59.73 - $65.4 $33,269 - $36,427
-557 Reduced 3.12%
17,281 $1.1 Million
Q2 2017

Jun 03, 2019

BUY
N/A
1,522 Added 9.33%
17,838 $1.11 Million
Q1 2017

Jun 03, 2019

BUY
N/A
203 Added 1.26%
16,316 $871,000
Q4 2016

Jun 03, 2019

BUY
N/A
15,067 Added 1440.44%
16,113 $863,000
Q2 2016

Jun 03, 2019

BUY
N/A
812 Added 347.01%
1,046 $50,000
Q1 2016

Jun 03, 2019

BUY
N/A
234
234 $22,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.